[1] Petrova P, Raibekas A, Pevsner J, et al. MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons [J]. J Mol Neurosci, 2003, 20(2): 173-188.
[2] Lindholm P, Voutilainen MH, Lauren J, et al. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo [J]. Nature, 2007, 448(7149): 73-77.
[3] Voutilainen MH, Back S, Porsti E, et al. Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson’s disease [J]. J Neurosci, 2009, 29(30): 9651-9659.
[4] Gao FJ, Wu JH, Li TT, et al. Identification of mesencephalic astrocyte-derived neurotrophic factor as a novel neuroprotective factor for retinal ganglion cells [J]. Front Mol Neurosci, 2017, 10: 76.
[5] Hartley CL, Edwards S, Mullan L, et al. Armet/Manf and Creld2 are components of a specialized ER stress response provoked by inappropriate formation of disulphide bonds: implications for genetic skeletal diseases [J]. Hum Mol Genet, 2013, 22(25): 5262-5275.
[6] Apostolou A, Shen Y, Liang Y, et al. Armet, a UPR-upregulated protein, inhibits cell proliferation and ER stress-induced cell death [J]. Exp Cell Res, 2008, 314(13): 2454-2467.
[7] Liu J, Zhou C, Tao X, et al. ER stress-inducible protein MANF selectively expresses in human spleen [J]. Hum Immunol, 2015, 76(11): 823-830.
[8] Arrieta A, Blackwood EA, Stauffer WT, et al. Mesencephalic astrocyte-derived neurotrophic factor is an ER-resident chaperone that protects against reductive stress in the heart [J]. J Biol Chem, 2020, 295(22): 7566-7583.
[9] Danilova T, Belevich I, Li H, et al. MANF is required for the postnatal expansion and maintenance of pancreatic beta-cell mass in mice [J]. Diabetes, 2019, 68(1): 66-80.
[10] Liu XC, Qi XH, Fang H, et al. Increased MANF expression in the inferior temporal gyrus in patients with Alzheimer disease [J]. Front Aging Neurosci, 2021, 13: 639318.
[11] Fu J, Malale K, Luo X, et al. The relationship of mesencephalic astrocyte-derived neurotrophic factor with hyperlipidemia in patients with or without type 2 diabetes mellitus [J]. Hormones (Athens), 2021, 20(3): 537-543.
[12]Wang C, Peng JJ, Miao H, et al. Decreased plasma MANF levels are associated with type 2 diabetes [J]. Biomed Environ Sci, 2021, 34(3): 236-240.
[13]Galli E, Planken A, Kadastik-Eerme L, et al. Increased serum levels of mesencephalic astrocyte-derived neurotrophic factor in subjects with Parkinson’s disease [J]. Front Neurosci, 2019, 13: 929.
[14]Kovaleva V, Saarma M. Endoplasmic reticulum stress regulators: new drug targets for Parkinson’s disease [J]. J Parkinson Dis, 2021, 11(s2): S219-S228.
[15]Xiang ChCh, Han F, Shi YX. Regulation of unfolded protein response by activated transcription factor 6 pathway and related regulatory factors in endoplasmic reticulum stress [J]. Acta Anatomica Sinica, 2015, 46(6): 857-861. (in Chinese)
向春晨, 韩芳, 石玉秀. 内质网应激中活化转录因子6通路及相关调控因子对未折叠蛋白反应的调控 [J]. 解剖学报, 2015, 46(6): 857-861.
[16]Gao FJ, Zhang SH, Li TT, et al. Expression and distribution of mesencephalic astrocyte-derived neurotrophic factor in the retina and optic nerve [J]. Front Hum Neurosci, 2017, 10: 686.
[17]Liu J, Wu Z, Han D, et al. Mesencephalic astrocyte-derived neurotrophic factor inhibits liver cancer through small ubiquitin-related modifier (SUMO)ylation-related suppression of NF-kappaB/Snail signaling pathway and epithelial-mesenchymal transition [J]. Hepatology, 2020, 71(4): 1262-1278.
|